These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20001629)

  • 1. Prevention of hemoglobinopathies in Syria.
    Al-Zir KN
    Hemoglobin; 2009; 33 Suppl 1():S25-7. PubMed ID: 20001629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steps toward the prevention of hemoglobinopathies in the kingdom of Saudi Arabia.
    Al-Shahrani M
    Hemoglobin; 2009; 33 Suppl 1():S21-4. PubMed ID: 20001628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hemoglobinopathies in Egypt.
    El-Beshlawy A; Youssry I
    Hemoglobin; 2009; 33 Suppl 1():S14-20. PubMed ID: 20001619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies.
    Giordano PC
    Clin Biochem; 2009 Dec; 42(18):1757-66. PubMed ID: 19591814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemoglobinopathies: their geographical distribution, etiopathogenesis, diagnosis and treatment and prevention principles].
    Tokarev IuN
    Ter Arkh; 1988; 60(5):62-6. PubMed ID: 3175932
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.
    Amato A; Grisanti P; Lerone M; Ponzini D; Di Biagio P; Cappabianca MP; Giordano PC
    Prenat Diagn; 2009 Dec; 29(12):1171-4. PubMed ID: 19816879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
    Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
    Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phitsanulok population: the highest incidence of hemoglobin E in the northern provinces of Thailand and PND counseling.
    Pravatmuang P; Tiloklurs M; Suannum M; Chaipat C
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():266-70. PubMed ID: 8629121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of hemoglobinopathies in Brussels: a necessity?].
    Gulbis B; Cotton F; Hansen V; Ferster A; Toppet M; Cochaux P; Parma J; Vassart G; Fondu P; Vertongen F
    Rev Med Brux; 2001 Jun; 22(3):133-40. PubMed ID: 11488080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and attitude toward the hemoglobinopathies premarital screening program in Saudi Arabia: population-based survey.
    Al Sulaiman A; Suliman A; Al Mishari M; Al Sawadi A; Owaidah TM
    Hemoglobin; 2008; 32(6):531-8. PubMed ID: 19065330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study.
    Giordano PC; Plancke A; Van Meir CA; Janssen CA; Kok PJ; Van Rooijen-Nijdam IH; Tanis BC; van Huisseling JC; Versteegh FG
    Prenat Diagn; 2006 Aug; 26(8):719-24. PubMed ID: 16752436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
    [No Abstract]   [Full Text] [Related]  

  • 15. Requirements for a reference or expert thalassemia center: the structure/model for centers dealing with chronic/hereditary blood disorders.
    Angastiniotis M; Eleftheriou A
    Hemoglobin; 2009; 33 Suppl 1():S204-10. PubMed ID: 20001627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.
    Giambona A; Passarello C; Renda D; Maggio A
    Clin Biochem; 2009 Dec; 42(18):1786-96. PubMed ID: 19591816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Student screening for inherited blood disorders in Bahrain.
    Al-Arrayed S; Hafadh N; Amin S; Al-Mukhareq H; Sanad H
    East Mediterr Health J; 2003 May; 9(3):344-52. PubMed ID: 15751927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
    Schoen EJ; Marks SM; Clemons MM; Bachman RP
    Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies.
    Patrinos GP; Kollia P; Papadakis MN
    Hum Mutat; 2005 Nov; 26(5):399-412. PubMed ID: 16138310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterozygote detection for hemoglobinopathies: situation in the Netherlands as compared to the British].
    Wierenga KJ; Luteijn AJ
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):326-7. PubMed ID: 10221090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.